Role of cardiac magnetic resonance in stratifying arrhythmogenic risk in mitral valve prolapse patients: a systematic review and meta-analysis.

Marco GattiAmbra SantonocitoFrancesco Pio PapaFabrizio D'AscenzoOvidio De FilippoGuglielmo GalloneAnna PalmisanoLorenzo PistelliGaetano Maria De FerrariAntonio EspositoCarla GiustettoPaolo FonioRiccardo Faletti

Published in: European radiology (2024)

MVP affects 2-3% of the population, with some facing increased risk for arrhythmia. LGE can assess arrhythmia risk, and MAD may further stratify patients. CMR is critical for MVP arrhythmia risk stratification, making it essential in a comprehensive evaluation.

Keyphrases

magnetic resonance
end stage renal disease
mitral valve
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
left ventricular
magnetic resonance imaging
heart failure
computed tomography
left atrial
catheter ablation
contrast enhanced